Medicinal Inorganic Chemistry Approaches to Passivation and Removal of Aberrant Metal Ions in Disease

2009 ◽  
Vol 109 (10) ◽  
pp. 4885-4910 ◽  
Author(s):  
Lauren E. Scott ◽  
Chris Orvig
RSC Advances ◽  
2021 ◽  
Vol 11 (26) ◽  
pp. 15663-15674
Author(s):  
Neha Choudhary ◽  
Kendall E. Barrett ◽  
Manja Kubeil ◽  
Valery Radchenko ◽  
Jonathan W. Engle ◽  
...  

The bisoxine hexadentate chelating ligand, H3glyox was investigated for its affinity for Mn2+, Cu2+ and Lu3+ ions; all three metal ions are relevant with applications in nuclear medicine and medicinal inorganic chemistry.


2012 ◽  
Vol 65 (9) ◽  
pp. 1325 ◽  
Author(s):  
Nathan L. Kilah ◽  
Eric Meggers

Sixty years ago, the Australian chemist Francis P. Dwyer pioneered the use of ruthenium polypyridyl complexes as biologically active compounds. These chemically inert and configurationally stable complexes revealed an astonishing range of interesting biological activities, such as the inhibition of the enzyme acetylcholinesterase, anti-cancer activity in vivo, and bacteriostatic/bacteriocidal action. This review commemorates the sixtieth anniversary of Dwyer and co-workers’ landmark 1952 publication, summarises their broader achievements in biological inorganic chemistry, and discusses the contribution of this work to the development of modern biological and medicinal inorganic chemistry.


Sign in / Sign up

Export Citation Format

Share Document